Developer docs
API playgroundTry for free, no card

Search company profiles

Biome Australia

Full company profile

uuid002bxz8

Namestring
Biome Australia
Legal namestring
Biome Australia Trading Pty Ltd
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Biome Australia Trading Pty Ltd is an Australian developer and marketer of live biotherapeutic products and complementary medicines, founded in 2018 and headquartered in Collingwood, Victoria. The company operates through its flagship brand, Activated Probiotics®, a practitioner-only range of precision probiotics and live biotherapeutic formulations targeted at specific health conditions including bone density, immune health, irritable bowel syndrome, vaginal health, eczema, acne, mood, and sleep. The company does not sell direct-to-consumer; all products are dispensed exclusively through certified healthcare practitioners such as pharmacists, nutritionists, and naturopaths, which supports premium pricing and positions the brand behind the counter as a clinically evidenced alternative to mass-market probiotic supplements.

The company's product portfolio is built on live biotherapeutic formulations with proprietary delivery technologies designed to improve stability and target-site efficacy. Each product is supported by randomized, double-blind, placebo-controlled clinical trials, a meaningful differentiator in the consumer probiotics category where most competitors rely on general health claims rather than indication-specific evidence. The company partners with world-leading microbiome research organizations to underpin its R&D pipeline and maintains a dual chief scientific officer structure, with Dr. Jaroslav Boublik as Chief Scientific Officer and Dr. Marco Pane serving in a CSO capacity alongside his role as R&D Manager at Probiotical SpA Italy, the company's manufacturing partner. The Activated Probiotics® trademark is held in the company's name.

Biome Australia generates revenue from wholesale product sales of its Activated Probiotics® range, distributed exclusively through its practitioner network. The practitioner-only channel is built on clinical education and professional recommendation, which both restricts volume relative to OTC distribution and supports higher unit margins. The company operates in Australia and has expanded into the EU/UK through a dedicated General Manager (Josh Stanford) based in Camberley, UK. The company is a private limited company with no disclosed revenue, headcount, or external funding rounds. Founder/Managing Director Blair Vega Norfolk leads the business, with Geoff Sam OAM as Chairman.

Short descriptiontext

Biome Australia develops and markets evidence-based live biotherapeutic products under its Activated Probiotics® brand. The company sells practitioner-only precision probiotics through certified pharmacists, nutritionists, and naturopaths across Australia and Europe, targeting specific health conditions including IBS, mood, sleep, and immune health.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCollingwood, Australia
HQ citystring
Collingwood
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
live biotherapeutics, precision probiotics, complementary medicines, gut microbiome health, practitioner-only supplements
Industry2 codes
1Probiotics & Digestive Health Supplements
CodeCRADAGAFPrimaryYes
2Probiotics (Strains, Spore-Formers, Synbiotic Components)
CodeAFAJAKAEPrimaryNo
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
Product category
Live Biotherapeutic Probiotics
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Probiotic Product Sales
TypeOne Time License
Description

Biome Australia generates revenue through the sale of Activated Probiotics, a range of live biotherapeutic and complementary medicine products distributed exclusively through healthcare practitioners. Products target specific health concerns including bone density, immune health, IBS, vaginal health, eczema, acne, mood, and sleep.

biomeaustralia.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Activated Probiotics
Description

A world-first range of live biotherapeutic products clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and IBS, through randomised double-blind placebo-controlled trials.

biomeaustralia.com
+1 more record
Core offering1 text field

Biome Australia develops, commercialises and markets the Activated Probiotics® range, a world-first portfolio of clinically validated live biotherapeutic and complementary medicine products targeting specific health concerns including low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. Products are sold exclusively through certified health professionals (pharmacists, nutritionists, naturopaths) in Australia and in European markets via a dedicated UK-based team.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Products clinically proven to help prevent and support management of low mood and sleep, bone health, iron malabsorption, mild eczema and IBS through randomised double-blind placebo-controlled trials
Product overview1 text field

Biome Australia is a health company that develops, commercialises and markets innovative, evidence-based live biotherapeutics and complementary medicines. The company's primary product offering is Activated Probiotics®, a practitioner-only range of precision probiotics. These products are backed by results from randomised, double-blind, placebo-controlled clinical trials and are available exclusively through certified health professionals such as pharmacists, nutritionists, and naturopaths. The Activated Probiotics® range targets specific health concerns including bone density, immune health, IBS, vaginal health, eczema, acne, mood, and sleep.

Product and service1 record
1Activated Probiotics®
CategoryLive biotherapeutic probiotics
Description

Activated Probiotics® is a practitioner-only range of precision probiotics containing live biotherapeutic products formulated to target specific aspects of health and wellbeing, including low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. Products are clinically validated through randomised double-blind placebo-controlled trials and sold exclusively through certified health professionals (pharmacists, nutritionists, naturopaths) in Australia and in European markets.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1World-leading microbiome research and development organisations
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Biome Australia partners with leading global organisations in microbiome research and development to produce unique live biotherapeutic products with innovative delivery technologies. This partnership enables the development of clinically proven products.

biomeaustralia.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Swedish probiotic specialist with clinically validated Lactobacillus reuteri strains sold globally across consumer and practitioner channels. Comparable in clinical-trial-led probiotic positioning and international distribution across Europe and APAC.

TypeDirect peer
Description

Practitioner-only nutritional medicine brand operating in Australia and globally, with a clinically substantiated probiotic range (e.g., MetaKids, MetaBiome). Closely comparable business model, practitioner-only channel, and evidence-based positioning to Biome Australia.

TypeEmerging player
Description

US-based, science-led DTC probiotic brand publishing clinical trial data across multiple indications. Comparable as an evidence-first, multi-indication probiotic brand, though operating in D2C versus practitioner-only.

TypeBroad incumbent
Description

Australia's largest complementary medicine brand, selling probiotics and gut-health products through pharmacy and practitioner channels. Comparable as a domestic Australian evidence-positioned supplement brand competing for the same shelf and practitioner recommendation, though at much larger scale.

TypeDirect peer
Description

Australian practitioner-only nutritional and therapeutic supplement brand, part of Blackmores Group, with a strong probiotics portfolio. Comparable in practitioner-only distribution model and complementary-medicine positioning.

6Ethical Nutrients
TypeDirect peer
Description

Australian practitioner and pharmacy probiotics brand (part of Metagenics) with clinically trialled formulations including IBS-focused strains. Comparable in evidence-based, practitioner-recommended Australian probiotic positioning.

TypeDirect peer
Description

European probiotic formulator selling multi-strain, clinically studied probiotic formulations primarily through healthcare practitioners. Comparable in evidence-led, practitioner-channel probiotic positioning and European footprint overlapping with Biome's EU/UK push.

TypeOthers
Description

Italian probiotic strain manufacturer and Biome Australia's R&D/manufacturing partner. Comparable as an upstream producer of probiotic strains used in finished supplements, and commercially linked via Biome's dual CSO appointment.

TypeBroad incumbent
Description

Mass-market Australian vitamins, supplements and probiotics brand owned by H&H Group, sold across pharmacy, grocery and online. Directly comparable premium gut-health positioning at significantly higher volume and broader distribution.

TypeRegional player
Description

Australian arm of Germany's Heel Group, offering practitioner-only combination/homeopathic and probiotic medicines. Comparable in practitioner-only Australian distribution and complementary-medicine positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biome Australia

Live Biotherapeutic Probioticsbiomeaustralia.com

Biome Australia develops and markets evidence-based live biotherapeutic products under its Activated Probiotics® brand. The company sells practitioner-only precision probiotics through certified pharmacists, nutritionists, and naturopaths across Australia and Europe, targeting specific health conditions including IBS, mood, sleep, and immune health.

What Biome Australia does

Biome Australia Trading Pty Ltd is an Australian developer and marketer of live biotherapeutic products and complementary medicines, founded in 2018 and headquartered in Collingwood, Victoria. The company operates through its flagship brand, Activated Probiotics®, a practitioner-only range of precision probiotics and live biotherapeutic formulations targeted at specific health conditions including bone density, immune health, irritable bowel syndrome, vaginal health, eczema, acne, mood, and sleep. The company does not sell direct-to-consumer; all products are dispensed exclusively through certified healthcare practitioners such as pharmacists, nutritionists, and naturopaths, which supports premium pricing and positions the brand behind the counter as a clinically evidenced alternative to mass-market probiotic supplements.

The company's product portfolio is built on live biotherapeutic formulations with proprietary delivery technologies designed to improve stability and target-site efficacy. Each product is supported by randomized, double-blind, placebo-controlled clinical trials, a meaningful differentiator in the consumer probiotics category where most competitors rely on general health claims rather than indication-specific evidence. The company partners with world-leading microbiome research organizations to underpin its R&D pipeline and maintains a dual chief scientific officer structure, with Dr. Jaroslav Boublik as Chief Scientific Officer and Dr. Marco Pane serving in a CSO capacity alongside his role as R&D Manager at Probiotical SpA Italy, the company's manufacturing partner. The Activated Probiotics® trademark is held in the company's name.

Biome Australia generates revenue from wholesale product sales of its Activated Probiotics® range, distributed exclusively through its practitioner network. The practitioner-only channel is built on clinical education and professional recommendation, which both restricts volume relative to OTC distribution and supports higher unit margins. The company operates in Australia and has expanded into the EU/UK through a dedicated General Manager (Josh Stanford) based in Camberley, UK. The company is a private limited company with no disclosed revenue, headcount, or external funding rounds. Founder/Managing Director Blair Vega Norfolk leads the business, with Geoff Sam OAM as Chairman.

Biome Australia firmographics

Firmographics
Name
Biome Australia
Legal name
Biome Australia Trading Pty Ltd
Website
https://biomeaustralia.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Biome Australia develops and markets evidence-based live biotherapeutic products under its Activated Probiotics® brand. The company sells practitioner-only precision probiotics through certified pharmacists, nutritionists, and naturopaths across Australia and Europe, targeting specific health conditions including IBS, mood, sleep, and immune health.
Ownership category
akta.pro rank

Biome Australia industry classification

Industry
Product category
Live Biotherapeutic Probiotics
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
akta.pro primary industry
Probiotics & Digestive Health Supplements (CRADAGAF)
akta.pro secondary industry
Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)

Keywords

  • Live biotherapeutics
  • Precision probiotics
  • Complementary medicines
  • Gut microbiome health
  • Practitioner-only supplements

Where Biome Australia is headquartered

Location

Headquarters

HQ city
Collingwood
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Biome Australia business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

  1. Probiotic Product Sales: Biome Australia generates revenue through the sale of Activated Probiotics, a range of live biotherapeutic and complementary medicine products distributed exclusively through healthcare practitioners. Products target specific health concerns including bone density, immune health, IBS, vaginal health, eczema, acne, mood, and sleep.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Biome Australia product offering

Product offering

Core offering

Biome Australia develops, commercialises and markets the Activated Probiotics® range, a world-first portfolio of clinically validated live biotherapeutic and complementary medicine products targeting specific health concerns including low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. Products are sold exclusively through certified health professionals (pharmacists, nutritionists, naturopaths) in Australia and in European markets via a dedicated UK-based team.

Product overview

Biome Australia is a health company that develops, commercialises and markets innovative, evidence-based live biotherapeutics and complementary medicines. The company's primary product offering is Activated Probiotics®, a practitioner-only range of precision probiotics. These products are backed by results from randomised, double-blind, placebo-controlled clinical trials and are available exclusively through certified health professionals such as pharmacists, nutritionists, and naturopaths. The Activated Probiotics® range targets specific health concerns including bone density, immune health, IBS, vaginal health, eczema, acne, mood, and sleep.

Differentiator

Problem solved

Functional benefit

Brands

  • Activated Probiotics: A world-first range of live biotherapeutic products clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and IBS, through randomised double-blind placebo-controlled trials.
  • Activated Probiotics

Products and services

  • Activated Probiotics® Activated Probiotics® is a practitioner-only range of precision probiotics containing live biotherapeutic products formulated to target specific aspects of health and wellbeing, including low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. Products are clinically validated through randomised double-blind placebo-controlled trials and sold exclusively through certified health professionals (pharmacists, nutritionists, naturopaths) in Australia and in European markets.

Quantifiable outcome

  • Products clinically proven to help prevent and support management of low mood and sleep, bone health, iron malabsorption, mild eczema and IBS through randomised double-blind placebo-controlled trials

Companies that use Biome Australia

Customer profile

Segments2 records

Ideal customer profiles2 records

Biome Australia technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Biome Australia partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • World-leading microbiome research and development organisationscoreStrategic or Co-development Partner · 1 January 2018Biome Australia partners with leading global organisations in microbiome research and development to produce unique live biotherapeutic products with innovative delivery technologies. This partnership enables the development of clinically proven products.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Biome Australia competitors and assessment

Company assessment

Broad incumbents

  • BioGaia: Swedish probiotic specialist with clinically validated Lactobacillus reuteri strains sold globally across consumer and practitioner channels. Comparable in clinical-trial-led probiotic positioning and international distribution across Europe and APAC.
  • Blackmores Limited: Australia's largest complementary medicine brand, selling probiotics and gut-health products through pharmacy and practitioner channels. Comparable as a domestic Australian evidence-positioned supplement brand competing for the same shelf and practitioner recommendation, though at much larger scale.
  • Swisse Wellness: Mass-market Australian vitamins, supplements and probiotics brand owned by H&H Group, sold across pharmacy, grocery and online. Directly comparable premium gut-health positioning at significantly higher volume and broader distribution.

Direct peers

  • Metagenics: Practitioner-only nutritional medicine brand operating in Australia and globally, with a clinically substantiated probiotic range (e.g., MetaKids, MetaBiome). Closely comparable business model, practitioner-only channel, and evidence-based positioning to Biome Australia.
  • BioCeuticals: Australian practitioner-only nutritional and therapeutic supplement brand, part of Blackmores Group, with a strong probiotics portfolio. Comparable in practitioner-only distribution model and complementary-medicine positioning.
  • Ethical Nutrients: Australian practitioner and pharmacy probiotics brand (part of Metagenics) with clinically trialled formulations including IBS-focused strains. Comparable in evidence-based, practitioner-recommended Australian probiotic positioning.
  • Winclove Probiotics: European probiotic formulator selling multi-strain, clinically studied probiotic formulations primarily through healthcare practitioners. Comparable in evidence-led, practitioner-channel probiotic positioning and European footprint overlapping with Biome's EU/UK push.

Emerging players

  • Seed Health: US-based, science-led DTC probiotic brand publishing clinical trial data across multiple indications. Comparable as an evidence-first, multi-indication probiotic brand, though operating in D2C versus practitioner-only.

Others

  • Probiotical SpA: Italian probiotic strain manufacturer and Biome Australia's R&D/manufacturing partner. Comparable as an upstream producer of probiotic strains used in finished supplements, and commercially linked via Biome's dual CSO appointment.

Regional players

  • Heel Australia: Australian arm of Germany's Heel Group, offering practitioner-only combination/homeopathic and probiotic medicines. Comparable in practitioner-only Australian distribution and complementary-medicine positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Biome Australia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biome Australia leadership team

Management profile

Number of profiles

Profiles11 records

Biome Australia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biome Australia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biome Australia

What does Biome Australia do?

Biome Australia develops, commercialises and markets the Activated Probiotics® range, a world-first portfolio of clinically validated live biotherapeutic and complementary medicine products targeting specific health concerns including low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. Products are sold exclusively through certified health professionals (pharmacists, nutritionists, naturopaths) in Australia and in European markets via a dedicated UK-based team.

Is Biome Australia a public or private company?

Biome Australia is a private company. It is classified as public and is currently operating.

When was Biome Australia founded?

Biome Australia was founded in 2018. It employs 11 to 50 people.

Where is Biome Australia based?

Biome Australia is headquartered in Collingwood, Australia, in the Oceania region.

How does Biome Australia make money?

One revenue line is on record: probiotic Product Sales.

Who are Biome Australia's main competitors?

Broad incumbents on record are BioGaia, Blackmores Limited and Swisse Wellness. Direct peers are Metagenics, BioCeuticals, Ethical Nutrients and Winclove Probiotics. Seed Health is listed as an emerging player. Probiotical SpA is listed as an others. Heel Australia is listed as a regional player.

Does Biome Australia have an API?

No public API is recorded for Biome Australia.

What industry is Biome Australia in?

Biome Australia's product category is Live Biotherapeutic Probiotics. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of AFAJAKAE, Probiotics (Strains, Spore-Formers, Synbiotic Components). Its NAICS code is 325414.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TradingViewBIO: FY26 delivered record revenue, profit, and margin, with global expansion and new China entry aheadBIO reported record FY26 results with revenue rising 30% to $23.9m and a gross margin of 62.1%. Distribution expanded to 7,500 points of sale, international markets contributed $1.8m, and onshore manufacturing plus a China launch are planned.Investing.comEarnings call transcript: Biome posts record FY 2026 sales, cash flow in Q4 2026 By Investing.comBiome Australia reported record FY 2026 revenue of AUD 23.9 million, up 30% from the prior year, alongside a swing to positive operating cash flow of AUD 1.6 million from an outflow of AUD 1.4 million, marking its strongest year on record. The company's flagship Biome Daily became the number one probiotic product in Australian pharmacy by both units and dollar value, while it signed a binding onshore manufacturing agreement with Specialty Probiotics Australia and advanced its first wholly proprietary probiotic strain BMB18 into a multi-center clinical trial. Management reaffirmed confidence in reaching its Vision 2027 target of AUD 32 million-plus in annual revenue, expecting FY 2027 first half to be its highest revenue-generating period on record.LinkedInBiologica Raises $7M in Seed Funding for Hormone Health SupplementsBiome Australia Group reported Q2 FY26 sales revenue of $6.48 million, representing a 40.9% increase year-over-year and a 9.1% sequential rise over Q1 FY26, despite the quarter typically being seasonally softer due to reduced December trading days. For the first half of FY26, the company's sales revenue reached $12.42 million, up 40.2% from the prior corresponding period, driven by strong demand for its Activated Probiotics range of clinically-proven live biotherapeutics and complementary medicines. The ASX-listed company's flagship practitioner-only product line targets health concerns including low mood, sleep issues, bone health, iron malabsorption, mild eczema, and IBS.YahooBiome Australia Full Year 2025 Earnings: In Line With ExpectationsBiome Australia reported full-year 2025 revenue of AU$18.4m, up 42% year-on-year, and net income of AU$214.7k, reversing a prior loss. The company's shares fell 3.6% from a week ago, and revenue is forecast to grow 32% annually over the next three years.